Chargement en cours...
Severe CIDP-MGUS responsive to Rituximab
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a relatively rare disease with progressive limb weakness and sensory loss. A few patients show a severely progressing course without major response to intravenous immunoglobulin or plasma exchange therapy. CIDP-MGUS (monoclonal gammopathy o...
Enregistré dans:
| Publié dans: | Heliyon |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7306592/ https://ncbi.nlm.nih.gov/pubmed/32596526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2020.e04230 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|